Investigation and pending class action lawsuit on behalf of direct purchasers for the opioid analgensic, Oxycontin.
The class action complaint alleges that Purdue Pharmaceuticals, L.P. obtained patents protecting Oxycontin by defrauding the U.S. Patent and Trademark Office, leading it to believe the drug was novel, when in fact many prior opioid painkillers presaged Oxycontin.
Do not change medications without first consulting your doctor.
Name (Stock Symbol)
Purdue Pharmaceuticals is a pharmaceutical company.
The information provided on ClassAdvocate.com is general in nature,
does not apply to any particular factual situation, and is not and
should not be taken as legal or other professional advice. We make no
commitment or warranty that the factual, legal or any other information
on ClassAdvocate.com, or on any linked website, is accurate, complete,
error-free, or current. As such, you should not rely on such information,
and should seek professional advice if and as you determine appropriate.
ClassAdvocate.com is not a lawyer referral service, and no attorney-client
or confidential relationship is or should be formed by use of the site.
The investigations listed on ClassAdvocate.com are attorney advertisements
and do not in any way constitute a referral or endorsement by ClassAdvocate.com
or any approved or authorized lawyer referral service.